Since ARBs block the biologic effects of angiotensin II more completely than ACE inhibitors, they could be beneficial in the treatment of heart failure. In a direct comparison trial (ELITE-II ...

[18] Whether or not this between class difference exists for ACE inhibitors and ARBs in CHF patients will be determined only by larger comparison studies.

Meet mild, reversible acute kidney injury (AKI) -- a sudden loss of kidney function that can go away within 24 hours or, if unchecked, can lead to chronic kidney failure, dialysis or transplant! It ...

Instead, a different type of medication called thiazide diuretics may work better and cause fewer side effects. Doctors have ...

In the past, heart disease was predominantly considered a men's health issue. Now we know it doesn't discriminate. In fact, ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...